甲状腺功能与肌少症:ELSA-Brasil研究结果
该横断面研究纳入6974名50岁及以上无显性甲状腺功能异常的社区居住者,评估亚临床甲状腺疾病及甲状腺激素水平与肌少症及其定义组分的关联。结果显示亚临床甲状腺功能障碍与肌少症无关,但在老年人中促甲状腺激素(TSH)与肌少症及低肌力呈U形关联,游离三碘甲状腺原氨酸(FT3)与肌肉量呈负相关。
要点
- 亚临床甲状腺功能异常与肌少症及其组分无显著关联。
- 老年人中TSH与肌少症及低肌力呈U形关联。
- FT3在中年和老年人群中均与肌肉量呈负相关。
核心结论
- 在无显性甲状腺功能异常的社区中老年人群中,细微的甲状腺激素变化与肌少症或其定义组分相关。
研究设计与样本
- 横断面研究,纳入ELSA-Brasil研究第二波中6974名50岁及以上、无显性甲状腺功能异常且暴露、结局和协变量数据完整的参与者。
主要发现
- 亚临床甲状腺功能障碍与肌少症及其定义组分无关联。
- 在老年人中,TSH与肌少症及低肌力呈U形关联:第一、第二、第四和第五分位与肌少症的OR(95%CI)分别为5.18(1.47-18.28)、6.28(1.82-21.73)、4.12(1.15-14.76)和4.81(1.35-17.10);第一、第二和第五分位与低肌力的OR(95%CI)分别为1.43(1.16-5.07)、2.07(1.24-4.70)和2.18(1.03-4.60)。
- FT3在中年和老年两个年龄层中均与肌肉量呈负相关。
关键数值与推荐
- 肌少症根据Foundation for the National Institutes of Health标准定义。
- 肌肉量通过生物电阻抗分析评估,肌力通过握力评估。
- 血清TSH、游离甲状腺素和游离三碘甲状腺原氨酸水平 measured 并分为五分位进行分析。
临床怎么用
- 对于无显性甲状腺功能异常的老年人,评估肌少症风险时需关注TSH的U形关联及FT3与肌肉量的负相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We aimed to investigate the association of subclinical thyroid disease and thyroid hormone levels with sarcopenia and its defining components in community-dwelling middle-aged and older adults without overt thyroid dysfunction. DESIGN: Cross-sectional study. SETTING: Active and retired employees from public institutions located in six Brazilian cities. PARTICIPANTS: A total of 6974 participants from the ELSA-Brasil study's second wave, aged 50 years and older, without overt thyroid dysfunction and with complete data for exposure, outcome, and covariates. METHODS: Serum levels of thyrotropin (TSH), free thyroxine, and free triiodothyronine (FT3) were measured and divided in quintiles for the analyses. Participants were classified with euthyroidism, subclinical hypothyroidism, and subclinical hyperthyroidism. Muscle mass was assessed by bioelectrical impedance analysis and muscle strength by handgrip strength. Sarcopenia was defined according to the Foundation for the National Institutes of Health criteria. Possible confounders included sociodemographic characteristics, clinical conditions, and lifestyle. Analyses were performed separately for middle-aged and older adults (≥65 y). RESULTS: The frequencies of sarcopenia, low muscle mass, low muscle strength, subclinical hypothyroidism, and subclinical hyperthyroidism were 1.5%, 20.8%, 3.8%, 9.1%, and .9%, respectively. Subclinical thyroid dysfunction was not associated with sarcopenia and its defining components. Among older adults, TSH had a U-shaped association with sarcopenia and low muscle strength. The odds ratios (ORs) (95% confidence intervals [CIs]) for the associations of the first, second, fourth, and fifth quintile with sarcopenia, respectively, were 5.18 (1.47-18.28), 6.28 (1.82-21.73), 4.12 (1.15-14.76), and 4.81 (1.35-17.10), and with low muscle strength was (OR (95% CI) for the first, second, and fifth quintiles, respectively: 1.43 (1.16-5.07), 2.07 (1.24-4.70), and 2.18 (1.03-4.60). Additionally, FT3 had a negative association with muscle mass in both age strata. CONCLUSION: Subtle thyroid hormone alterations are associated with sarcopenia or its defining components in middle-aged and older adults without overt thyroid dysfunction. J Am Geriatr Soc 68:1545-1553, 2020.
引用
- Szlejf C, Suemoto CK, Janovsky CCPS, et al. Thyroid Function and Sarcopenia: Results from the ELSA-Brasil Study. J Am Geriatr Soc. 2020. PMID: 32167571. doi:10.1111/jgs.16416
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。